These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2917340)

  • 21. General structure of "fecapentaenes"--the mutagenic substances in human faeces: a preliminary report.
    Bruce WR; Baptista J; Che T; Furrer R; Gingerich JS; Gupta I; Krepinsky JJ; Grey AA; Yates P
    Naturwissenschaften; 1982 Nov; 69(11):557-8. PubMed ID: 7155190
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluation of fecal mutagenicity and colorectal cancer risk.
    de Kok TM; van Maanen JM
    Mutat Res; 2000 Jul; 463(1):53-101. PubMed ID: 10838209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutagenic activities of fecapentaene derivatives in the Ames/Salmonella test system.
    Peters JH; Riccio ES; Stewart KR; Reist EJ
    Cancer Lett; 1988 Apr; 39(3):287-96. PubMed ID: 3282644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The precursors of fecapentaenes: purification and properties of a novel plasmalogen.
    Van Tassell RL; Piccariello T; Kingston DG; Wilkins TD
    Lipids; 1989 May; 24(5):454-9. PubMed ID: 2755322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of fecapentaenes on nuclear aberrations in murine colonic epithelial cells.
    Vaughan DJ; Furrer R; Baptista J; Krepinsky JJ
    Cancer Lett; 1987 Oct; 37(2):199-203. PubMed ID: 3677054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and biological activity of analogs of fecapentaene-12.
    Govindan SV; Kingston DG; Gunatilaka AA; van Tassell RL; Wilkins TD; de Wit PP; van der Steeg M; van der Gen A
    J Nat Prod; 1987; 50(1):75-83. PubMed ID: 3598600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Noncovalent DNA binding and the mechanism of oxidative DNA damage by fecapentaene-12.
    Szekely J; Gates KS
    Chem Res Toxicol; 2006 Jan; 19(1):117-21. PubMed ID: 16411664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reactivity of fecapentaene-12 toward thiols, DNA, and these constituents in human fibroblasts.
    Dypbukt JM; Edman CC; Sundqvist K; Kakefuda T; Plummer SM; Harris CC; Grafström RC
    Cancer Res; 1989 Nov; 49(21):6058-63. PubMed ID: 2790820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electron spin resonance spectroscopy of oxygen radicals generated by synthetic fecapentaene-12 and reduction of fecapentaene mutagenicity to Salmonella typhimurium by hydroxyl radical scavenging.
    de Kok TM; van Maanen JM; Lankelma J; ten Hoor F; Kleinjans JC
    Carcinogenesis; 1992 Jul; 13(7):1249-55. PubMed ID: 1322251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genotoxic mechanisms of fecapentaene-12 in human cells.
    Povey AC; Plummer SM; Grafstrom RC; Harris CC
    Prog Clin Biol Res; 1990; 347():155-66. PubMed ID: 2217387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation and structure elucidation of fecapentaenes-12, potent mutagens from human feces.
    Hirai N; Kingston DG; Van Tassell RL; Wilkins TD
    J Nat Prod; 1985; 48(4):622-30. PubMed ID: 4045474
    [No Abstract]   [Full Text] [Related]  

  • 32. Characterization of a mutagenic bacterial product in human feces.
    Wilkins TD; Lederman M; Van Tassell RL; Kingston DG; Henion J
    Am J Clin Nutr; 1980 Nov; 33(11 Suppl):2513-20. PubMed ID: 7001887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutagenicity of different fractions of extracts of human feces.
    Dion P; Bruce WR
    Mutat Res; 1983 Feb; 119(2):151-60. PubMed ID: 6828051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The precursors of fecapentaenes. A preliminary report.
    Van Tassell RL; Wilkins TD
    Ann Ist Super Sanita; 1986; 22(3):933-41. PubMed ID: 3826998
    [No Abstract]   [Full Text] [Related]  

  • 35. Fecapentaene causes sister-chromatid exchanges in human lymphocytes.
    Bauchinger M; Bartha R; Schmid E; Pfaendler HR
    Mutat Res; 1988; 209(1-2):29-31. PubMed ID: 3173400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formation of 8-hydroxydeoxyguanosine in DNA treated with fecapentaene-12 and -14.
    Shioya M; Wakabayashi K; Yamashita K; Nagao M; Sugimura T
    Mutat Res; 1989 Mar; 225(3):91-4. PubMed ID: 2927433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A model study of fecapentaenes: mutagens of bacterial origin with alkylating properties.
    Gupta I; Suzuki K; Bruce RW; Krepinsky JJ; Yates P
    Science; 1984 Aug; 225(4661):521-3. PubMed ID: 6377497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of a fecapentaene on protein kinase C.
    Hoshina S; Ueffing M; Morotomi M; Weinstein IB
    Biochem Biophys Res Commun; 1991 Apr; 176(1):505-10. PubMed ID: 2018537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The fecapentaenes, potent mutagens from human feces.
    Kingston DG; Van Tassell RL; Wilkins TD
    Chem Res Toxicol; 1990; 3(5):391-400. PubMed ID: 2133089
    [No Abstract]   [Full Text] [Related]  

  • 40. Biochemical epidemiology of colon cancer: effect of types of dietary fiber on fecal mutagens, acid, and neutral sterols in healthy subjects.
    Reddy B; Engle A; Katsifis S; Simi B; Bartram HP; Perrino P; Mahan C
    Cancer Res; 1989 Aug; 49(16):4629-35. PubMed ID: 2545348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.